Mario Corso
Investor Relations Contact at FORMA THERAPEUTICS HOLDINGS, INC.
Profile
Mario V.
Corso is currently the Head-Investor Relations at Forma Therapeutics Holdings, Inc. He previously worked as a Managing Director at Caris & Co., Inc. from 2010 to 2011.
He also worked as an Analyst at ABN AMRO Rothschild LLC, Mizuho Securities USA LLC, and Leerink Partners LLC.
From 2008 to 2009, he was an Analyst at Monomoy Asset Management LLC.
He was also the Senior Director-Investor Relations at ObsEva SA and the Head-Investor Relations at Compass Therapeutics, Inc. Mr. Corso holds an MBA from Northeastern University and an undergraduate degree from the University of Connecticut.
Mario Corso active positions
Companies | Position | Start |
---|---|---|
FORMA THERAPEUTICS HOLDINGS, INC. | Investor Relations Contact | 01/09/2020 |
Former positions of Mario Corso
Companies | Position | End |
---|---|---|
Caris & Co., Inc.
Caris & Co., Inc. Investment Banks/BrokersFinance Founded by Darren Caris in 2002, Caris & Co., Inc. is a broker/dealer headquartered in Del Mar, California. The firm is a subsidiary of B. Riley & Co. They offer research that is independent of their investment banking activities, as well as a full array of trading and execution services. Caris & Co.'s coverage includes large-, mid- and small-cap companies in the healthcare, technology, energy and consumer sectors. Their research is written for the longer-term investor with an investment horizon of at least 12 months. Caris & Co., Inc. is a member of the NASD and the SIPC. | Analyst-Equity | 31/12/2011 |
Monomoy Asset Management LLC
Monomoy Asset Management LLC Investment ManagersFinance Founded in 2008 by Michael Hearle, Monomoy Asset Management is a hedge fund manager located in Boston. They manage the Monomoy Healthcare Fund. | Analyst-Equity | 31/05/2009 |
ABN AMRO Rothschild LLC
ABN AMRO Rothschild LLC Investment Banks/BrokersFinance Established in 1996, ABN AMRO Rothschild LLC is the equity capital markets partnership between the ABN AMRO and Rothschild groups. They deliver ECM solutions for clients around the world. ABN AMRO originates and conducts primary and secondary offerings including IPOs, block trades, accelerated book build transactions, rights issues, share buy backs, convertible and exchangeable bonds and structured equity transactions. They are located in New York City and have offices worldwide. | Analyst-Equity | - |
COMPASS THERAPEUTICS, INC. | Investor Relations Contact | - |
OBSEVA SA | Investor Relations Contact | - |
Training of Mario Corso
University of Connecticut | Undergraduate Degree |
Northeastern University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
OBSEVA SA | Health Technology |
COMPASS THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
ABN AMRO Rothschild LLC
ABN AMRO Rothschild LLC Investment Banks/BrokersFinance Established in 1996, ABN AMRO Rothschild LLC is the equity capital markets partnership between the ABN AMRO and Rothschild groups. They deliver ECM solutions for clients around the world. ABN AMRO originates and conducts primary and secondary offerings including IPOs, block trades, accelerated book build transactions, rights issues, share buy backs, convertible and exchangeable bonds and structured equity transactions. They are located in New York City and have offices worldwide. | Finance |
Monomoy Asset Management LLC
Monomoy Asset Management LLC Investment ManagersFinance Founded in 2008 by Michael Hearle, Monomoy Asset Management is a hedge fund manager located in Boston. They manage the Monomoy Healthcare Fund. | Finance |
Caris & Co., Inc.
Caris & Co., Inc. Investment Banks/BrokersFinance Founded by Darren Caris in 2002, Caris & Co., Inc. is a broker/dealer headquartered in Del Mar, California. The firm is a subsidiary of B. Riley & Co. They offer research that is independent of their investment banking activities, as well as a full array of trading and execution services. Caris & Co.'s coverage includes large-, mid- and small-cap companies in the healthcare, technology, energy and consumer sectors. Their research is written for the longer-term investor with an investment horizon of at least 12 months. Caris & Co., Inc. is a member of the NASD and the SIPC. | Finance |
Mizuho Securities USA LLC
Mizuho Securities USA LLC Investment Banks/BrokersFinance Mizuho Securities USA LLC is the US-based securities broker/dealer and futures commission merchant arm of Mizuho Americas LLC, ultimately held by Mizuho Financial Group, Inc. (TYO: 8411, NYSE: MFG) in Japan. Headquartered in New York City, the firm was founded in 1994 and provides institutional and corporate clients access to commodity and financial markets around the world. Mizuho Securities USA covers the following industries: Consumer, Energy, Financial Institutions, Financial Sponsors, Healthcare, Industrial & Diversified Industries, Power, Utilities & Infrastructure, Real Estate, and Technology, Media & Telecom (TMT). The firm and their affiliates hold memberships on all major futures and options exchanges worldwide. | Finance |
Forma Therapeutics Holdings, Inc.
Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA. | Health Technology |
- Stock Market
- Insiders
- Mario Corso